A company producing synthetic RNA for agricultural and biomedical applications is now a public company after a special-purpose acquisition. . . . → Read More: RNA Manufacturer Goes Public in $282M Merger
|
|||||
       
  |
 Comments are closed  Finance  agriculture, biomedical, biotechnology, chemistry, Covid-19, entrepreneurs, equity, investment, IPO, life sciences, manufacturing, merger, physical sciences 
Drug maker Bayer is acquiring a company discovering new therapies with a technology that reveals complex protein targets considered difficult to address. . . . → Read More: Protein Chemistry Biotech Acquired in $2B Deal One comment - (Comments are closed) Finance biomedical, biotechnology, chemistry, entrepreneurs, Europe, investment, life sciences, merger, pharmaceuticals, physical sciences, preclinical 
Drug maker Sanofi is purchasing biotechnology company Translate Bio, a developer of messenger RNA vaccines and therapies, and a long-time collaborator. . . . → Read More: Sanofi Acquires mRNA Developer in $3.2B Deal One comment - (Comments are closed) Finance, Joint ventures/collaborations biomedical, biotechnology, clinical trials, Covid-19, equity, Europe, genomics, investment, life sciences, merger, pharmaceuticals 
A new enterprise discovering treatments for neurodegenerative diseases is merging with another start-up and raising $73 million its first venture round. . . . → Read More: Neuro Disease Start-Up Raises $73M in Early Funds One comment - (Comments are closed) Finance, New products biomedical, biotechnology, entrepreneurs, equity, Europe, genomics, investment, life sciences, merger, pharmaceuticals, university, venture capital 
A company developing synthetic biology and engineering tools for biotechnology is becoming a public company through a special-purpose acquisition. . . . → Read More: Synthetic Bio Company Goes Public in $2.5B Merger Comments are closed Finance biotechnology, economics, engineering, entrepreneurs, equity, genomics, investment, IPO, life sciences, merger, pharmaceuticals 
A biotechnology company using protein dynamics to develop precision cancer therapies is acquiring a drug discovery company based on machine learning algorithms. . . . → Read More: AI Drug Discovery Company Acquired in $270M Deal Comments are closed Finance biomedical, biotechnology, cancer, chemistry, engineering, equity, genomics, investment, life sciences, mathematics, merger, physical sciences
GenMark Diagnostics, a developer of diagnostics systems using genomic analysis, was acquired by drug maker Roche in a deal valued at $1.8 billion. . . . → Read More: Molecular Diagnostics Company Acquired in $1.8B Deal Comments are closed Finance biomedical, biotechnology, engineering, equity, investment, life sciences, medical device, merger, physical sciences, university 
A developer of therapies using highly precise gene editing is acquiring a company delivering gene therapies identified with DNA bar codes. . . . → Read More: Gene-Editing Biotech Acquires DNA Bar Code Company One comment - (Comments are closed) Finance, New products biomedical, biotechnology, entrepreneurs, equity, genomics, investment, life sciences, merger, pharmaceuticals, university 
A developer of treatments for rare neurological diseases derived from cannabis is being acquired by Jazz Pharmaceuticals in a $7.2 billion deal. . . . → Read More: Cannabidiol Drug Maker Acquired in $7.2B Deal Comments are closed Finance biomedical, cancer, equity, Europe, investment, life sciences, merger, pharmaceuticals, U.K. 
Total venture investments in dollars jumped to a new high in the U.S., while biotechnology remained the single hottest sector in 2020. . . . → Read More: 2020 Venture Funds Mixed, Biotech Keeps Sizzling One comment - (Comments are closed) Finance biotechnology, economics, equity, investment, IPO, merger, software, venture capital |
|
|||
|
Copyright © 2021 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
